Source: International Congress 2017 – Clinical update on bronchiectasis and nontuberculous mycobacteria (NTM) infections
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. Smith (Dundee, United Kingdom). Sputum Pregnancy Zone Protein (PZP) - a potential biomarker of bronchiectasis severity. 1969

Member's Comments

No comment yet.

Related content which might interest you: Sputum YKL-40 is a potential biomarker of COPD-asthma overlap Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 Serum periostin in asthma: A potential biomarker for stratification in severe treatment-resistant asthma Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Conduct of a biomarker study in bronchiectasis patients: Correlation of neutrophil elastase activity and inflammatory load in induced sputum Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 Serum periostin in obstructive airways disease: Range, relationships and response to corticosteroid Source: International Congress 2014 – New mechanisms in the pathogenesis of asthma and other lung diseases Year: 2014 Comparison of three methods for preparation of bronchiectasis sputum supernatents for biomarker measurement Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical and functional characterisation Year: 2015 C-reactive protein and pulmonary tuberculosis: What correlation with disease severity Source: International Congress 2015 – Management of TB: a patient focus Year: 2015 Sputum interleukin (IL)-13 as a biomarker for the evaluation of asthma control Source: International Congress 2014 – Airway biomarkers Year: 2014 Activin –A and follistatin in sputum supernatant and BAL in patients with asthma Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013 Concentration of C-reactive protein (CRP) in elderly asthmatics Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms Year: 2015 Endothelial microparticles in sputum of COPD patients: A potential biomarker of disease Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015 Sputum neutrophil differential cell count in health and relationship to disease severity in asthma Source: International Congress 2014 – Phenotyping and monitoring asthma and COPD Year: 2014 Diagnostic implications of sTREM-1 in induced sputum and BAL fluid of patients with asthma and COPD Source: International Congress 2015 – Modulating the immune system in COPD and asthma Year: 2015 Fibrinogen and CRP biomarkers in patients with exacerbation of COPD group C and D Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Assessing sarcoidosis activity: Is serum chitotriosidase a reliable marker? Study of 430 patients and 264 healthy controls Source: International Congress 2014 – Pathogenetic mechanisms in pulmonary fibrosis Year: 2014 Human neutrophil gelatinase-associated lipocalin: A new biomarker in asthma-COPD overlap syndrome Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma Year: 2016 Dialysis plus ultrafiltration significantly improves the detection of cytokines in induced sputum Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013 Hydrogen sulfide (H2S) in sputum and serum as a novel biomarker of COPD Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Long-term efficacy of omalizumab (OMA) for patients with severe allergic asthma (SAA). Clinical assessment and relationship to serum IgE concentrations Source: International Congress 2015 – The immunology of allergic airway disease Year: 2015 Serum Levels of Club-Cell Protein 16 (CC-16), Surfactant Protein D (SPD), soluble Receptor of Glycation End-products (sRAGE), Fibrinogen and C-Reactive Protein (CRP) and FEV1 Decline, Exacerbations and Mortality in SUMMIT Source: International Congress 2017 – Towards personalised medicine in COPD: biological and clinical phenotypes Year: 2017 Interleukins in induced sputum and plasma of COPD and asthma patients in indian population: Correlation with respiratory indices and cell counts Source: International Congress 2016 – Airway biomarkers Year: 2016